Kinomica Limited

KinaSense

The company develops peptide-based biosensors and diagnostic methods to monitor kinase activity for cancer patients and clinical researchers.

PhoreMost

This biopharmaceutical company develops a phenotypic screening platform to identify new drug targets for pharmaceutical and biotechnology partners in oncology and inflammation.

Kinnate Biopharma

The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.

Celleron Therapeutics

This biopharmaceutical company develops precision medicine drugs and companion diagnostics for cancer patients to provide personalised oncology treatments.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

Oxford Cancer Biomarkers

This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.

Kiyatec

This company develops 3D cell culture platforms to predict patient-specific responses to cancer therapies for oncologists and biopharmaceutical companies.

Acrivon Therapeutics

This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.